NEW YORK DEC 18, 2006 (Reuters Health) - Epirubicin-based induction and maintenance chemotherapy leads to relatively high long-term survival rates in women with unilateral inflammatory breast cancer, French researchers report in the December 1st issue of Cancer......
Use the following link to read the complete story: Epirubicin-Based Regimen Treats Inflammatory Breast Cancer
No comments:
Post a Comment